In other countries
The same active substances on other registers, the same brand first.
- SkyriziBrazil · Abbvie Farmacêutica Ltda.Same brand
- SKYRIZI 150 mg SOLUCION INYECTABLE EN JERINGA PRECARGADASpain · 150 mg · solución inyectable en jeringa precargada · Abbvie Deutschland Gmbh & Co. KgSame brand
- SKYRIZI 150 mg SOLUCION INYECTABLE EN PLUMA PRECARGADASpain · 150 mg · solución inyectable en pluma precargada · Abbvie Deutschland Gmbh & Co. KgSame brand
- Skyrizi 180 MG Solucion Inyectable en CartuchoSpain · 180 mg · solución inyectable en cartucho · Abbvie Deutschland Gmbh & Co. KgSame brand
- SkyriziEuropean Union · AbbVie Deutschland GmbH & Co. KGSame brand
- SkyriziCroatiaSame brand
- SkyriziItaly · Soluzione iniettabile · Abbvie Deutschland GMBH & Co. KGSame brand
- Skyrizi 150 mg, oplossing voor injectie in voorgevulde penNetherlands · Oplossing voor injectie · AbbVie Deutschland GmbH & Co. KGSame brand
- Skyrizi 150 mg, oplossing voor injectie in voorgevulde spuitNetherlands · Oplossing voor injectie · AbbVie Deutschland GmbH & Co. KGSame brand
- Skyrizi 180 mg oplossing voor injectie in een patroonNetherlands · Oplossing voor injectie · AbbVie Deutschland GmbH & Co. KGSame brand
- SKYRIZI 75 mgRomania · 75mg/0.83ml · sol. inj. in seringa preumpluta · Abbvie Deutschland GMBH & Co KGSame brand
- Skyrizi®Serbia · 150mg/mL · rastvor za injekciju u napunjenom injekcionom penu · Abbvie D.O.O. BeogradSame brand
- Skyrizi®Serbia · 75mg · rastvor za injekciju u napunjenom injekcionom špricu · Abbvie D.O.O. BeogradSame brand
- Skyrizi 150 mgSaudi Arabia · AbbVie Deutschland GmbH & Co KGSame brand
- Skyrizi 360 mg per 2.4 mlSaudi Arabia · Patheon Italia S.P.A.Same brand
- Skyrizi 600 mg per 10 mlSaudi Arabia · AbbVie LimitedSame brand
- Skyrizi Solution for Injection in Pre-Filled Syringe 150MG/MLSingapore · 150mg/mL · injection, solution · Abbvie Pte. LTD.Same brand
- Skyrizi Concentrate for Solution for Infusion 600MG/10MLSingapore · 600mg/10mL · infusion, solution concentrate · Abbvie Pte. LTD.Same brand
- Skyrizi Solution for Injection in Pre-Filled Cartridge with On-Body Injector 180MG/1.2MLSingapore · 180mg/1.2mL · injection, solution · Abbvie Pte. LTD.Same brand
- SkyriziUnited States · 150MG/ML, 75MG/0.83ML · injectable · Abbvie INCSame brand
- SkyriziUnited States · 150MG/ML · Injection · AbbVie Inc.Same brand
- SkyriziUnited States · 90MG/ML · Injection · AbbVie Inc.Same brand
Documents
The official texts, at the regulator.
Sources and licences
Compiled by Prognia from the public register below; the register’s text is the official one.
Health Canada, Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada · Added 13 Oct 2026
Report an error or request removalCorrections from the holder or the register are welcome.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Active substance
- Risankizumab
- Strength
- 60 MG / ML
- Dosage form
- Solution
- Route
- Intravenous
- Register
- Canada (Health Canada)
- Status
- Marketed
- Authorised
- 1 Dec 2022
- Registration
- DIN 02532107
- Marketing authorisation holder
- Abbvie Corporation
- ATC code
- L04AC18
- Supply
- PRESCRIPTION, SCHEDULE D